Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT04605575 · UNKNOWN

Trial details

NCT number: NCT04605575
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Pyrotinib Breast Diseases Vinorelbine HER2-positive Breast Cancer

Start date: 2020-05-22
Primary completion: 2023-08-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.